Page last updated: 2024-10-15

pteroylpentaglutamic acid

Cross-References

ID SourceID
PubMed CID135483919
CHEBI ID140748
MeSH IDM0112033

Synonyms (16)

Synonym
33611-85-7
l-glutamic acid, n-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-l-.gamma.-glutamyl-l-.gamma.-glutamyl-l-.gamma.-glutamyl-l-.gamma.-glutamyl-
(2s)-2-[[(4s)-4-[[(4s)-4-[[(4s)-4-[[(4s)-4-[[4-[(2-amino-4-hydroxy-pteridin-6-yl)methylamino]benzoyl]amino]-5-hydroxy-5-oxo-pentanoyl]amino]-5-hydroxy-5-oxo-pentanoyl]amino]-5-hydroxy-5-oxo-pentanoyl]amino]-5-hydroxy-5-oxo-pentanoyl]amino]pentanedioic aci
pteroylpentaglutamic acid
CHEBI:140748
pentaglutamyl folate
pteroylpentaglutamate
pte-penta-glu
l-glutamic acid, n-(n-(n-(n-(n-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-l-gamma-glutamyl)-l-gamma-glutamyl)-l-gamma-glutamyl)-l-gamma-glutamyl)-
nsc 372667
(2s)-2-[(4s)-4-[(4s)-4-[(4s)-4-[(4s)-4-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]-4-carboxybutanamido]-4-carboxybutanamido]-4-carboxybutanamido]-4-carboxybutanamido]pentanedioic acid
DTXSID60187306
(2s)-2-[[(4s)-4-[[(4s)-4-[[(4s)-4-[[(4s)-4-[[4-[(2-amino-4-oxo-1h-pteridin-6-yl)methylamino]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid
(2s)-2-[[(4s)-4-[[(4s)-4-[[(4s)-4-[[(4s)-4-[[4-[(2-amino-4-oxo-3h-pteridin-6-yl)methylamino]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid
AKOS040753648
(3s,8s,13s,18s,23s)-1-(4-(((2-amino-4-oxo-4,8-dihydropteridin-6-yl)methyl)amino)phenyl)-1,6,11,16,21-pentaoxo-2,7,12,17,22-pentaazapentacosane-3,8,13,18,23,25-hexacarboxylic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (44.44)18.7374
1990's3 (33.33)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (10.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]